Global Parkinsons Disease Drug Market Size, Share, Trends and Forecast 2020-2026

Description

This report focuses on Parkinson's Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

TABLE OF CONTENT

Table of Contents

1 Parkinson's Disease Drug Market Overview
1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Parkinson's Disease Drug Segment by Type
1.2.1 Global Parkinson's Disease Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Parkinson's Disease Drug Segment by Application
1.3.1 Parkinson's Disease Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson's Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Parkinson's Disease Drug Revenue 2015-2026
1.4.2 Global Parkinson's Disease Drug Sales 2015-2026
1.4.3 Parkinson's Disease Drug Market Size by Region: 2020 Versus 2026

2 Global Parkinson's Disease Drug Market Competition by Manufacturers
2.1 Global Parkinson's Disease Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Parkinson's Disease Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Parkinson's Disease Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Parkinson's Disease Drug Manufacturing Sites, Area Served, Product Type
2.5 Parkinson's Disease Drug Market Competitive Situation and Trends
2.5.1 Parkinson's Disease Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Parkinson's Disease Drug Players (Opinion Leaders)

3 Parkinson's Disease Drug Retrospective Market Scenario by Region
3.1 Global Parkinson's Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Parkinson's Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Parkinson's Disease Drug Market Facts & Figures by Country
3.3.1 North America Parkinson's Disease Drug Sales by Country
3.3.2 North America Parkinson's Disease Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Parkinson's Disease Drug Market Facts & Figures by Country
3.4.1 Europe Parkinson's Disease Drug Sales by Country
3.4.2 Europe Parkinson's Disease Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parkinson's Disease Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Parkinson's Disease Drug Sales by Region
3.5.2 Asia Pacific Parkinson's Disease Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parkinson's Disease Drug Market Facts & Figures by Country
3.6.1 Latin America Parkinson's Disease Drug Sales by Country
3.6.2 Latin America Parkinson's Disease Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Parkinson's Disease Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Parkinson's Disease Drug Sales by Country
3.7.2 Middle East and Africa Parkinson's Disease Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Parkinson's Disease Drug Historic Market Analysis by Type
4.1 Global Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
4.2 Global Parkinson's Disease Drug Revenue Market Share by Type (2015-2020)
4.3 Global Parkinson's Disease Drug Price Market Share by Type (2015-2020)
4.4 Global Parkinson's Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Parkinson's Disease Drug Historic Market Analysis by Application
5.1 Global Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
5.2 Global Parkinson's Disease Drug Revenue Market Share by Application (2015-2020)
5.3 Global Parkinson's Disease Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Parkinson's Disease Drug Business
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Akorn
6.2.1 Akorn Parkinson's Disease Drug Production Sites and Area Served
6.2.2 Akorn Description, Business Overview and Total Revenue
6.2.3 Akorn Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Akorn Products Offered
6.2.5 Akorn Recent Development
6.3 GSK
6.3.1 GSK Parkinson's Disease Drug Production Sites and Area Served
6.3.2 GSK Description, Business Overview and Total Revenue
6.3.3 GSK Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GSK Products Offered
6.3.5 GSK Recent Development
6.4 Novartis
6.4.1 Novartis Parkinson's Disease Drug Production Sites and Area Served
6.4.2 Novartis Description, Business Overview and Total Revenue
6.4.3 Novartis Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.4.5 Novartis Recent Development
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Parkinson's Disease Drug Production Sites and Area Served
6.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.5.3 Boehringer Ingelheim Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Boehringer Ingelheim Products Offered
6.5.5 Boehringer Ingelheim Recent Development
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Parkinson's Disease Drug Production Sites and Area Served
6.6.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Teva Pharmaceutical Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Teva Pharmaceutical Products Offered
6.6.5 Teva Pharmaceutical Recent Development
6.7 Abbvie
6.6.1 Abbvie Parkinson's Disease Drug Production Sites and Area Served
6.6.2 Abbvie Description, Business Overview and Total Revenue
6.6.3 Abbvie Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Abbvie Products Offered
6.7.5 Abbvie Recent Development
6.8 Kyowa Hakko Kirin Pharma
6.8.1 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Sites and Area Served
6.8.2 Kyowa Hakko Kirin Pharma Description, Business Overview and Total Revenue
6.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Kyowa Hakko Kirin Pharma Products Offered
6.8.5 Kyowa Hakko Kirin Pharma Recent Development
6.9 Astellas Pharma
6.9.1 Astellas Pharma Parkinson's Disease Drug Production Sites and Area Served
6.9.2 Astellas Pharma Description, Business Overview and Total Revenue
6.9.3 Astellas Pharma Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Astellas Pharma Products Offered
6.9.5 Astellas Pharma Recent Development
6.10 Desitin Arzneimittel
6.10.1 Desitin Arzneimittel Parkinson's Disease Drug Production Sites and Area Served
6.10.2 Desitin Arzneimittel Description, Business Overview and Total Revenue
6.10.3 Desitin Arzneimittel Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Desitin Arzneimittel Products Offered
6.10.5 Desitin Arzneimittel Recent Development
6.11 Endo Pharmaceuticals
6.11.1 Endo Pharmaceuticals Parkinson's Disease Drug Production Sites and Area Served
6.11.2 Endo Pharmaceuticals Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.11.3 Endo Pharmaceuticals Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Endo Pharmaceuticals Products Offered
6.11.5 Endo Pharmaceuticals Recent Development
6.12 F.Hoffmann-La Roche
6.12.1 F.Hoffmann-La Roche Parkinson's Disease Drug Production Sites and Area Served
6.12.2 F.Hoffmann-La Roche Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.12.3 F.Hoffmann-La Roche Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 F.Hoffmann-La Roche Products Offered
6.12.5 F.Hoffmann-La Roche Recent Development
6.13 H.Lundbeck
6.13.1 H.Lundbeck Parkinson's Disease Drug Production Sites and Area Served
6.13.2 H.Lundbeck Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.13.3 H.Lundbeck Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 H.Lundbeck Products Offered
6.13.5 H.Lundbeck Recent Development
6.14 Valeant
6.14.1 Valeant Parkinson's Disease Drug Production Sites and Area Served
6.14.2 Valeant Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.14.3 Valeant Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Valeant Products Offered
6.14.5 Valeant Recent Development
6.15 Apokyn
6.15.1 Apokyn Parkinson's Disease Drug Production Sites and Area Served
6.15.2 Apokyn Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.15.3 Apokyn Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Apokyn Products Offered
6.15.5 Apokyn Recent Development
6.16 Orion
6.16.1 Orion Parkinson's Disease Drug Production Sites and Area Served
6.16.2 Orion Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.16.3 Orion Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Orion Products Offered
6.16.5 Orion Recent Development
6.17 Stada Arzneimittel
6.17.1 Stada Arzneimittel Parkinson's Disease Drug Production Sites and Area Served
6.17.2 Stada Arzneimittel Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.17.3 Stada Arzneimittel Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Stada Arzneimittel Products Offered
6.17.5 Stada Arzneimittel Recent Development
6.18 US WorldMeds
6.18.1 US WorldMeds Parkinson's Disease Drug Production Sites and Area Served
6.18.2 US WorldMeds Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.18.3 US WorldMeds Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.18.4 US WorldMeds Products Offered
6.18.5 US WorldMeds Recent Development
6.19 Bausch Health
6.19.1 Bausch Health Parkinson's Disease Drug Production Sites and Area Served
6.19.2 Bausch Health Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.19.3 Bausch Health Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Bausch Health Products Offered
6.19.5 Bausch Health Recent Development

7 Parkinson's Disease Drug Manufacturing Cost Analysis
7.1 Parkinson's Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parkinson's Disease Drug
7.4 Parkinson's Disease Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parkinson's Disease Drug Distributors List
8.3 Parkinson's Disease Drug Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Parkinson's Disease Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parkinson's Disease Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Parkinson's Disease Drug by Type (2021-2026)
10.2 Parkinson's Disease Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parkinson's Disease Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Parkinson's Disease Drug by Application (2021-2026)
10.3 Parkinson's Disease Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parkinson's Disease Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Parkinson's Disease Drug by Region (2021-2026)
10.4 North America Parkinson's Disease Drug Estimates and Projections (2021-2026)
10.5 Europe Parkinson's Disease Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Parkinson's Disease Drug Estimates and Projections (2021-2026)
10.7 Latin America Parkinson's Disease Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Parkinson's Disease Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample